Zobrazeno 1 - 10
of 308
pro vyhledávání: '"Kalpadakis, C."'
Background/Aim: Primary mediastinal large Bcell lymphoma (PMLBCL) is an aggressive B-cell non- Hodgkin lymphoma (NHL), whose prognosis has greatly improved since the incorporation of the anti-CD20 monoclonal antibody rituximab into current therapeuti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::aac0fd8434bc5524bf5c24e52f2d534c
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3219445
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3219445
End-of-treatment (EoT) PET/CT is used as a guide to omit radiotherapy (RT) patients with primary mediastinal large B-cell lymphoma (PMBCL). We present the mature and extended results of a retrospective study evaluating the prognostic significance of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::3bb976ff80b447b9a8f16d9cd7908710
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3119407
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3119407
Transplant-ineligible relapsed/refractory (rr) diffuse large B-cell lymphoma (DLBCL) patients represent an unmet medical need. Polatuzumab vedotin (Pola), an anti-CD79b antibody-drug-conjugate (ADG), with bendamustine- rituximab(BR) has recently gain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::fe73a15e7db58341a50f122221c530c5
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3076389
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3076389
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Background: Only few studies have focused exclusively on patients with small lymphocytic lymphoma (SLL). Patients and Methods: In the present report, 103 SLL patients were analyzed from both, clinical trials of the German Chronic Lymphocytic Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::f7a190521af420ac50c41b5828306fbe
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3079080
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3079080
The B cell receptor immunoglobulin (Ig) gene repertoires of marginal zone (MZ) lymphoproliferations were analyzed in order to obtain insight into their ontogenetic relationships. Our cohort included cases with MZ lymphomas (n = 488), i.e. splenic (SM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::b5396bff2725dc66a7ab872c63332440
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3106137
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3106137
This retrospective study aimed to describe the Hellenic experience on the use of brentuximab vedotin (BV) in relapsed/refractory (R/R) Hodgkin lymphoma (HL) given within its indication. From June 2011 to April 2015, ninety-five patients with R/R HL,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::69c4e1cdc6c7e2f9f8086fa1ea1455b3
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3086446
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3086446